Developing a menstrual-blood test for endometriosis with home sample collection
Endometriosis can cause severe menstrual pain, chronic pelvic pain and infertility. Its varied symptoms can make diagnosis difficult, and long delays are common. Ultrasound can support diagnosis, while surgery may be needed to confirm it; access to early diagnosis remains limited in many settings.
Diamens is developing an endometriosis test using menstrual blood collected at home and analysed by PCR in a laboratory. Its ongoing multicentre study is assessing the approach, with participant feedback on sample collection and shipping already reported.
What stands out about Diamens
Closed a pre-seed round led by eQventure, joined by VP Venture Partners, FS Life Science Investment and VGW Beteiligungs.
An ongoing multicentre study is assessing the test approach, with participant feedback on collection and shipping reported.
Städtisches Klinikum Karlsruhe joined as a clinical partner, adding the study's first German site.
Received the Rudolf Sallinger Fonds S&B Award 2026, recognising work at the intersection of science and business.
CEO and co-founder Marlene Rezk-Füreder holds a Medical Sciences PhD and lists research on menstrual and endometrial health.
CEO Marlene Rezk-Füreder previously co-founded inQmate; her profile records the role beginning in January 2022.
Completed tech2b's Incubate programme; the programme provider names Diamens among its graduating startups.
Diamens has built a prototype of its menstrual-blood endometriosis test and is evaluating it in an ongoing clinical study.
Get a curated pipeline of healthcare and life sciences startups aligned with your investment thesis.